← Back to Search

Reinforcement Intervention for HIV Testing

N/A

Waitlist Available

Led By Kristyn Zajac, Ph.D.

Research Sponsored by UConn Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Female

18 and older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 15-month follow-up

Awards & highlights

Study Summary

This trial is testing whether providing reinforcement (monetary rewards) to high-risk women will increase their likelihood of getting HIV tested, compared to just providing referrals and education.

Who is the study for?

This trial is for African American, Latina, and women living in poverty who are at high risk for HIV. Participants must be female, speak English or Spanish, work with high-risk women as a case manager or clinician, have not had a recent HIV test or are not already HIV positive, and plan to stay employed at their agency.Check my eligibility

What is being tested?

The study tests if giving financial rewards can increase the rate of HIV testing among high-risk women. It compares standard referral services plus online education about HIV prevention against those same services with added cash incentives for getting tested now and again after certain periods.See study design

What are the potential side effects?

There are no direct medical side effects from participating in this trial since it involves behavioral interventions rather than medications. However, participants may experience stress or anxiety related to testing and waiting for results.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am female.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 15-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~15-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 15-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Clinician knowledge

HIV testing by clients

Secondary outcome measures

Client HIV knowledge

Clinician satisfaction with training

HIV Risk Reduction Module Completion

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Treatment Group BExperimental Treatment3 Interventions

Standard referral for HIV testing and online HIV risk reduction training plus reinforcement

Group II: Treatment Group AActive Control2 Interventions

Standard referral for HIV testing and online HIV risk reduction training

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Reinforcement

2014

N/A

~100

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

UConn HealthLead Sponsor

211 Previous Clinical Trials

60,287 Total Patients Enrolled

National Institute on Minority Health and Health Disparities (NIMHD)NIH

383 Previous Clinical Trials

1,215,877 Total Patients Enrolled

Kristyn Zajac, Ph.D.Principal Investigator - UConn Health

UConn Health

1 Previous Clinical Trials

36 Total Patients Enrolled

Media Library

Reinforcement Clinical Trial Eligibility Overview. Trial Name: NCT03768986 — N/A

HIV/AIDS Research Study Groups: Treatment Group B, Treatment Group A

HIV/AIDS Clinical Trial 2023: Reinforcement Highlights & Side Effects. Trial Name: NCT03768986 — N/A

Reinforcement 2023 Treatment Timeline for Medical Study. Trial Name: NCT03768986 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many subjects are being monitored for this research endeavor?

"Affirmative. According to the records stored on clinicaltrials.gov, this medical study is actively searching for participants and was originally posted on February 4th 2019. Currently, 334 patients need to be recruited from a single centre; information has been recently updated as of June 16th 2022."

Answered by AI

Are participants being enrolled in the trial at this time?

"Affirmative. Clinicaltrials.gov data indicates that this research is actively enrolling participants, with 334 patients needed at a single site since its inception on February 4th 2019 and most recent update occurring June 16th 2022."

Answered by AI

What are the essential aims of this experiment?

"This medical trial will evaluate its primary outcome, clinician knowledge, over a 15-month period since the intervention began. The secondary outcomes include changes in HIV risk behaviours (measured by Human Immunodeficiency Virus Risk Behaviour Scale 0 to 55), self-reported HIV test results and client reported completion of online HIV risk reduction modules."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Reinforcement Intervention for Increasing HIV Testing Among At-Risk Women

Kristyn Zajac 2019. "A Reinforcement Intervention for Increasing HIV Testing Among At-Risk Women". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03768986.